Literature DB >> 24265646

A case of recurrent pulmonary inflammatory myofibroblastic tumor with aggressive metastasis after complete resection.

Chae Ho Moon1, Jong Ho Yoon, Geon Wook Kang, Seong Hyeon Lee, Jeong Su Baek, Seo Yun Kim, Hye-Ryoun Kim, Cheol Hyeon Kim.   

Abstract

An inflammatory myofibroblastic tumor (IMT) is a rare disease entity reported to arise in various organs. It is thought to be a neoplastic or reactive inflammatory condition, controversially. The treatment of choice for myofibroblastic tumor is surgery, and recurrence is known to be rare. The optimal treatment method is not well-known for patients ineligible for surgery. We report a 47-year-old patient with aggressive recurrent IMT of the lungs. The patient had been admitted for an evaluation of back-pain two years after a complete resection of pulmonary IMT. Radiation therapy was performed for multiple bone recurrences, and the symptoms were improved. However the patient presented again with aggravated back-pain six months later. High-dose steroid and non-steroidal anti-inflammatory drugs were administered, but the disease progressed aggressively, resulting in spinal cord compression and metastasis to intra-abdominal organs. This is a very rare case of aggressively recurrent pulmonary IMT with multi-organ metastasis.

Entities:  

Keywords:  Lung; Lung Neoplasms; Myofibroblasts; Neoplasm Metastasis; Recurrence

Year:  2013        PMID: 24265646      PMCID: PMC3833938          DOI: 10.4046/trd.2013.75.4.165

Source DB:  PubMed          Journal:  Tuberc Respir Dis (Seoul)        ISSN: 1738-3536


  7 in total

1.  The rationale for nonsteroidal anti-inflammatory drug therapy for inflammatory myofibroblastic tumors: a Children's Oncology Group study.

Authors:  Harry Applebaum; Mark W Kieran; Timothy P Cripe; Cheryl M Coffin; Margaret H Collins; Arja Kaipainen; Andrea Laforme; Robert C Shamberger
Journal:  J Pediatr Surg       Date:  2005-06       Impact factor: 2.545

2.  Multiple intraosseous inflammatory myofibroblastic tumors presenting with an aggressive clinical course: case report.

Authors:  Yasuo Sasagawa; Takuya Akai; Shoutarou Itou; Hideaki Iizuka
Journal:  Neurosurgery       Date:  2011-10       Impact factor: 4.654

3.  ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor.

Authors:  C M Coffin; A Patel; S Perkins; K S Elenitoba-Johnson; E Perlman; C A Griffin
Journal:  Mod Pathol       Date:  2001-06       Impact factor: 7.842

4.  Carboplatin plus paclitaxel in the successful treatment of advanced inflammatory myofibroblastic tumor.

Authors:  Naoki Kubo; Taishi Harada; Satoshi Anai; Kohei Otsubo; Yasuto Yoneshima; Kayo Ijichi; Takaomi Koga; Koichi Takayama; Yoichi Nakanishi
Journal:  Intern Med       Date:  2012-09-01       Impact factor: 1.271

5.  Inflammatory pseudotumors of the lung.

Authors:  R J Cerfolio; M S Allen; A G Nascimento; C Deschamps; V F Trastek; D L Miller; P C Pairolero
Journal:  Ann Thorac Surg       Date:  1999-04       Impact factor: 4.330

6.  [A case of rapidly growing inflammatory myofibroblastic tumor in the lung].

Authors:  Saiko Suetsugu; Hidetaka Yamamoto; Miiru Izumi; Koichi Takayama; Hiromasa Inoue; Yoichi Nakanishi
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2009-12

Review 7.  Inflammatory myofibroblastic tumor with bone marrow involvement. A case report and review of the literature.

Authors:  Christopher T Hagenstad; Scott E Kilpatrick; Mark J Pettenati; Paul D Savage
Journal:  Arch Pathol Lab Med       Date:  2003-07       Impact factor: 5.534

  7 in total
  5 in total

1.  Recurrent inflammatory myofibroblastic tumor of the inguinal region: A case report and review of the literature.

Authors:  Tian Zhang; Yawei Yuan; Chen Ren; Shasha DU; Jiarong Chen; Quanquan Sun; Zhengjun Liu
Journal:  Oncol Lett       Date:  2015-05-29       Impact factor: 2.967

Review 2.  Inflammatory myofibroblastic tumor of the lumbar spinal canal: A Case Report With Literature Review.

Authors:  Shanshan Wang; Liang Chen; Zhang Cao; Xijin Mao; Lin Zhang; Bin Wang
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

3.  Anaplastic lymphoma kinase-negative pulmonary inflammatory myofibroblastic tumor with multiple metastases and its treatment by Apatinib: A case report.

Authors:  Qiuxia Liu; Jianguo Wei; Xizhong Liu; Jianfang Wang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

4.  Inflammatory myofibroblastic tumor: a rare tumor of the lung.

Authors:  Özlem S İçmeli; Levent A Alpay; Baran Gündoğuş; Hatice Türker; Ayçim Şen
Journal:  Eur Clin Respir J       Date:  2014-08-19

5.  Microwave ablation for the management of pulmonary inflammatory myofibroblastic tumor: a case report and literature review.

Authors:  Yizhong Zhang; Guoping Zheng; Xiaopeng Meng; Yuanjing Li; Dan Shi; Jinna Yu
Journal:  Transl Cancer Res       Date:  2021-10       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.